EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:2618 - amantadine
| Formula | C10H17N |
| Net Charge | 0 |
| Average Mass | 151.253 |
| Monoisotopic Mass | 151.13610 |
| SMILES | NC12CC3CC(CC(C3)C1)C2 |
| InChI | InChI=1S/C10H17N/c11-10-4-7-1-8(5-10)3-9(2-7)6-10/h7-9H,1-6,11H2 |
| InChIKey | DKNWSYNQZKUICI-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Roles: | NMDA receptor antagonist Any substance that inhibits the action of N-methyl-D-aspartate (NMDA) receptors. They tend to induce a state known as dissociative anesthesia, marked by catalepsy, amnesia, and analgesia, while side effects can include hallucinations, nightmares, and confusion. Due to their psychotomimetic effects, many NMDA receptor antagonists are used as recreational drugs. antiviral drug A substance used in the prophylaxis or therapy of virus diseases. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. dopaminergic agent A drug used for its effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons. non-narcotic analgesic A drug that has principally analgesic, antipyretic and anti-inflammatory actions. Non-narcotic analgesics do not bind to opioid receptors. |
| Applications: | antiparkinson drug A drug used in the treatment of Parkinson's disease. antiviral drug A substance used in the prophylaxis or therapy of virus diseases. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. dopaminergic agent A drug used for its effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons. non-narcotic analgesic A drug that has principally analgesic, antipyretic and anti-inflammatory actions. Non-narcotic analgesics do not bind to opioid receptors. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| amantadine (CHEBI:2618) has parent hydride adamantane (CHEBI:40519) |
| amantadine (CHEBI:2618) has role analgesic (CHEBI:35480) |
| amantadine (CHEBI:2618) has role antiparkinson drug (CHEBI:48407) |
| amantadine (CHEBI:2618) has role antiviral drug (CHEBI:36044) |
| amantadine (CHEBI:2618) has role dopaminergic agent (CHEBI:48560) |
| amantadine (CHEBI:2618) has role NMDA receptor antagonist (CHEBI:60643) |
| amantadine (CHEBI:2618) has role non-narcotic analgesic (CHEBI:35481) |
| amantadine (CHEBI:2618) is a adamantanes (CHEBI:51339) |
| amantadine (CHEBI:2618) is a primary aliphatic amine (CHEBI:17062) |
| amantadine (CHEBI:2618) is conjugate base of adamantan-1-aminium (CHEBI:48320) |
| Incoming Relation(s) |
| adamantan-1-aminium (CHEBI:48320) is conjugate acid of amantadine (CHEBI:2618) |
| IUPAC Name |
|---|
| adamantan-1-ylamine |
| INNs | Source |
|---|---|
| amantadine | ChemIDplus |
| amantadinum | ChemIDplus |
| amantadina | ChemIDplus |
| Synonyms | Source |
|---|---|
| Amantadine | KEGG COMPOUND |
| 1-adamantylamine | ChEBI |
| 1-aminoadamantane | ChEBI |
| tricyclo[3.3.1.13,7]decan-1-ylamine | IUPAC |
| tricyclo[3.3.1.13,7]decan-1-amine | NIST Chemistry WebBook |
| tricyclo[3.3.1.13,7]decane-1-amine | NIST Chemistry WebBook |
| Brand Names | Source |
|---|---|
| Viregyt | ChemIDplus |
| Virosol | ChemIDplus |
| Citations |
|---|